Literature DB >> 10229231

Regulation of Fas ligand expression and cell death by apoptosis-linked gene 4.

E Lacana1, L D'Adamio.   

Abstract

Programmed cell death is a process required for the normal development of an organism. One of the best understood apoptotic pathways occurs in T lymphocytes and is mediated by Fas/Fas ligand (FasL) interaction. During studies of apoptosis induced by T cell-receptor engagement, we identified ALG-4F, a truncated transcript that prevents T cell-receptor-induced FasL upregulation and cell death. Overexpression of full-length ALG-4 induced transcription of FasL and, consequently, apoptosis. These results indicate that ALG-4 is necessary and sufficient for FasL expression. Fas/FasL interaction initiates cell death in many other systems, and its dysregulation is a mechanism by which several pathologic conditions arise. Understanding the molecular mechanisms of FasL regulation could be very useful in elucidating how these diseases develop and in identifying potential therapeutic targets.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10229231     DOI: 10.1038/8420

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  6 in total

1.  Programmed cell death 6 (PDCD6) as a prognostic marker for gastric cancers.

Authors:  Jung Hwan Yoon; Yoo Jin Choi; Sung Geun Kim; Suk Woo Nam; Jung Young Lee; Won Sang Park
Journal:  Tumour Biol       Date:  2011-12-13

2.  Multiethnic genome-wide association study of cerebral white matter hyperintensities on MRI.

Authors:  Benjamin F J Verhaaren; Stéphanie Debette; Joshua C Bis; Jennifer A Smith; M Kamran Ikram; Hieab H Adams; Ashley H Beecham; Kumar B Rajan; Lorna M Lopez; Sandra Barral; Mark A van Buchem; Jeroen van der Grond; Albert V Smith; Katrin Hegenscheid; Neelum T Aggarwal; Mariza de Andrade; Elizabeth J Atkinson; Marian Beekman; Alexa S Beiser; Susan H Blanton; Eric Boerwinkle; Adam M Brickman; R Nick Bryan; Ganesh Chauhan; Christopher P L H Chen; Vincent Chouraki; Anton J M de Craen; Fabrice Crivello; Ian J Deary; Joris Deelen; Philip L De Jager; Carole Dufouil; Mitchell S V Elkind; Denis A Evans; Paul Freudenberger; Rebecca F Gottesman; Vilmundur Guðnason; Mohamad Habes; Susan R Heckbert; Gerardo Heiss; Saima Hilal; Edith Hofer; Albert Hofman; Carla A Ibrahim-Verbaas; David S Knopman; Cora E Lewis; Jiemin Liao; David C M Liewald; Michelle Luciano; Aad van der Lugt; Oliver O Martinez; Richard Mayeux; Bernard Mazoyer; Mike Nalls; Matthias Nauck; Wiro J Niessen; Ben A Oostra; Bruce M Psaty; Kenneth M Rice; Jerome I Rotter; Bettina von Sarnowski; Helena Schmidt; Pamela J Schreiner; Maaike Schuur; Stephen S Sidney; Sigurdur Sigurdsson; P Eline Slagboom; David J M Stott; John C van Swieten; Alexander Teumer; Anna Maria Töglhofer; Matthew Traylor; Stella Trompet; Stephen T Turner; Christophe Tzourio; Hae-Won Uh; André G Uitterlinden; Meike W Vernooij; Jing J Wang; Tien Y Wong; Joanna M Wardlaw; B Gwen Windham; Katharina Wittfeld; Christiane Wolf; Clinton B Wright; Qiong Yang; Wei Zhao; Alex Zijdenbos; J Wouter Jukema; Ralph L Sacco; Sharon L R Kardia; Philippe Amouyel; Thomas H Mosley; W T Longstreth; Charles C DeCarli; Cornelia M van Duijn; Reinhold Schmidt; Lenore J Launer; Hans J Grabe; Sudha S Seshadri; M Arfan Ikram; Myriam Fornage
Journal:  Circ Cardiovasc Genet       Date:  2015-02-07

3.  Micronuclei in cord blood lymphocytes and associations with biomarkers of exposure to carcinogens and hormonally active factors, gene polymorphisms, and gene expression: the NewGeneris cohort.

Authors:  Domenico Franco Merlo; Silvia Agramunt; Lívia Anna; Harrie Besselink; Maria Botsivali; Nigel J Brady; Marcello Ceppi; Leda Chatzi; Bowang Chen; Ilse Decordier; Peter B Farmer; Sarah Fleming; Vincenzo Fontana; Asta Försti; Eleni Fthenou; Fabio Gallo; Panagiotis Georgiadis; Hans Gmuender; Roger W Godschalk; Berit Granum; Laura J Hardie; Kari Hemminki; Kevin Hochstenbach; Lisbeth E Knudsen; Manolis Kogevinas; Katalin Kovács; Soterios A Kyrtopoulos; Martinus Løvik; Jeanette K Nielsen; Unni Cecilie Nygaard; Marie Pedersen; Per Rydberg; Bernadette Schoket; Dan Segerbäck; Rajinder Singh; Jordi Sunyer; Margareta Törnqvist; Henk van Loveren; Frederik J van Schooten; Kim Vande Loock; Hans von Stedingk; John Wright; Jos C Kleinjans; Micheline Kirsch-Volders; Joost H M van Delft
Journal:  Environ Health Perspect       Date:  2013-11-19       Impact factor: 9.031

4.  Elevation of autoantibody level against PDCD11 in patients with transient ischemic attack.

Authors:  Yoichi Yoshida; Hao Wang; Takaki Hiwasa; Toshio Machida; Eiichi Kobayashi; Seiichiro Mine; Go Tomiyoshi; Rika Nakamura; Natsuko Shinmen; Hideyuki Kuroda; Hirotaka Takizawa; Koichi Kashiwado; Ikuo Kamitsukasa; Hideo Shin; Takeshi Wada; Akiyo Aotsuka; Eiichiro Nishi; Mikiko Ohno; Minoru Takemoto; Koutaro Yokote; Sho Takahashi; Jun Matsushima; Xiao-Meng Zhang; Masaki Takiguchi; Yasuo Iwadate
Journal:  Oncotarget       Date:  2017-12-24

Review 5.  Elevation of Autoantibody in Patients with Ischemic Stroke.

Authors:  Yoichi Yoshida; Takaki Hiwasa; Toshio Machida; Eiichi Kobayashi; Seiichiro Mine; Jun Matsushima; Masaki Takiguchi; Yasuo Iwadate
Journal:  Neurol Med Chir (Tokyo)       Date:  2018-05-31       Impact factor: 1.742

6.  The Transcription Profile Unveils the Cardioprotective Effect of Aspalathin against Lipid Toxicity in an In Vitro H9c2 Model.

Authors:  Rabia Johnson; Phiwayinkosi V Dludla; Christo J F Muller; Barbara Huisamen; M Faadiel Essop; Johan Louw
Journal:  Molecules       Date:  2017-01-31       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.